Your donation can fund the next ovarian cancer breakthrough
Women’s lives depend on research funding. Please make a tax-deductible donation before June 30.
Early detection saves lives
With your help, we’re funding early career researchers on the front-line of major breakthroughs in cancer detection and prevention.
Our Next Generation Cancer Research Fellowship recipient, Dr Mostafa Kamal Masud, is currently developing a device that will allow ovarian cancer to be diagnosed in GP clinics within just two hours.
Give Australian women a fighting chance for the future
70% of the 1,800 Australian women who are diagnosed each year already reached an advanced stage of cancer.
These are women like Jackie, a retired primary school teacher from Townsville, who went through the process of elimination – and misdiagnosis – for several months before she finally got diagnosed with ovarian cancer. By then, her cancer had progressed to stage 4, spreading from her left ovary to the lining of her abdominal cavity.
“Unlike breast cancer, which has early detection through the mammogram program, ovarian cancer does not have screening. Fewer than half of women who are diagnosed with ovarian cancer will survive for five years, and the earlier the diagnosis, the better the outcome,” Jackie says.
“I wish this device had been in my doctor’s office when I first started feeling pain. We need to do whatever it takes to get more research like this funded.”
Fund local cancer research, make a global impact
The discoveries Dr Masud is making in the field of nanoarchitectonics could change the way cancer is diagnosed.
“Every cancer expresses some sort of biomolecule related to that cancer. The advanced biosensor nanotechnology I am developing will be capable of detecting disease-relevant biomolecules like DNA, RNA, and proteins,” Dr Masud says.
“Our design, mesoporous nanostructures, which are very specific to those target molecules, can isolate the target biomolecules from body fluids within half an hour.”
The ripple effects this technology can have on cancer research cannot be understated.
We’re on the brink of a breakthrough
Ovarian cancer has a 49% 5-year survival rate. Each year, hundreds of Australian women die because their cancer is found too late.
Dr Masud’s device will save money, resources, and most importantly, lives.
“I wish this device had been in my doctor’s office when I first started feeling pain. We need to do whatever it takes to get more research like this funded,” says Jackie.
Donate to the brightest researchers working on the boldest projects and make breakthroughs like this happen.
